A p95HER2 hasadt receptorfehérjét expresszáló HER2-pozitív emlo″rákos betegek lapatinibalapú kezelésének klinikai elo″nye

Translated title of the contribution: Clinical benefits of lapatinib-based treatment of patients with HER2-positive breast cancer expressing the split receptor protein p95HER2

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageHungarian
Pages (from-to)393-394
Number of pages2
JournalLege Artis Medicinae
Issue number6-7
Publication statusPublished - Jun 1 2010

ASJC Scopus subject areas

  • Medicine(all)

Cite this